EClinCloud Collaborates with Leading Experts to Publish Practical Guidance on Electronic Scales for Psychiatric and Psychological Disorders

Chinese Journal of New Drugs and Clinical Remedies
, in its October issue, prominently published "Practical Guidance on the Electronic Implementation of Scales in Clinical Studies of Psychiatric and Psychological Disorders," co-authored by EClinCloud and leading experts in psychiatric disorders.
Chinese Journal of New Drugs and Clinical Remedies
was founded in 1982 and is a national academic journal of pharmaceutical science and technology co-sponsored by the Chinese Pharmaceutical Association and the Institute of Scientific and Technical Information of the Shanghai Food and Drug Administration.
As a China-based
eCOA proponent, EClinCloud's joint publication of this important guidance document on electronic scale implementation with leading experts will promote academic exchange and knowledge sharing, and provide valuable practical guidance for improving clinical trial quality and efficiency. This reflects EClinCloud's expertise and industry influence, and marks an important milestone in EClinCloud's development.
Scale digitization refers to the process of converting clinical outcome assessment (COA) instruments, such as traditional paper scales or questionnaires, into digital formats using electronic technology, making scale completion and reporting more convenient, timely, and accurate, and the collected data more complete, compliant, and secure.
Excerpt from "Practical Guidance on Scale Digitization in Clinical Research on Psychiatric and Psychological Disorders"
While scale digitization offers numerous advantages, requirements for applicable systems as well as device hardware and software, together with a professional understanding and breakdown of the scales, are all indispensable.
To this end, EClinCloud provides an integrated
eCOA solution, including services such as scale management and consulting, rater training, study electronic system build, and system training and quality control.
In the future, EClinCloud will contribute further to advancing clinical research in the pharmaceutical industry in a more scientific and efficient direction.


